FDA schedules meeting to curb 'robotripping' - WAOW - Newsline 9, Wausau News, Weather, Sports

FDA schedules meeting to curb 'robotripping'

WASHINGTON (AP) -- The Food and Drug Administration has scheduled a meeting to discuss ways to curb abuse of a key ingredient found in Robitussin and other cough suppressing medicines.

The FDA will ask a panel of outside experts to make recommendations on Sept. 14 to stop adolescents from abusing the ingredient dextromethorphan for its euphoric effects, sometimes called "robotripping."

The ingredient is found in a number of over-the-counter medicines made by Procter & Gamble, Johnson & Johnson, Pfizer and other consumer health companies.

In recent months Pfizer, J&J and other drugmakers have lobbied on efforts in Congress to reduce abuse of their medications.

State lawmakers are also pushing legislation that would tighten controls.

(Copyright 2010 by The Associated Press. All Rights Reserved.)

Powered by Frankly